European Journal of Medicinal Chemistry · 2015 · 62 citations · 30 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsLigand-based DesignMolecular DockingMolecular ModelingMolecular Targets Of DrugsProtein-ligand DockingStructure-activity Relationship AnalysisBenzimidazole ChemistryBenzimidazole SynthesisBiological Evaluation ReportDocking-based Drug DesignDrug Binding Sites On TubulinMolecular Docking Of InhibitorsTubulin Binding InhibitionTubulin Polymerization Inhibitors
30
I. Vermes, C. Haanen, H M Steffens-Nakken et al. · Journal of Immunological Methods · 1995 · 5.4K citations · Full text
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
G. Dark, S A Hill, Vivien E. Prise et al. · PubMed · 1997 · 624 citations
Medicine, Oncology, Pharmacology +13
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Mikhail V. Blagosklonny, Paraskevi Giannakakou, Wafik S. El‐Deiry et al. · PubMed · 1997 · 386 citations
Medicine, Oncology, Pharmacology +17
Arylthioindoles, Potent Inhibitors of Tubulin Polymerization
Gabriella Martino, Giuseppe La Regina, Antonio Coluccia et al. · Journal of Medicinal Chemistry · 2004 · 292 citations